v3.26.1
Preferred and Common Shares and Share-Based Compensation (Tables)
 6 Months Ended
Jul. 03, 2026
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Share-Based Compensation Expense Recorded in the Consolidated Statements of Operations

The table below summarizes share-based compensation expense recorded in the consolidated statements of operations (in thousands):

 

Three Months Ended

 

 

Six Months Ended

 

 

July 3,

 

 

June 27,

 

 

July 3,

 

 

June 27,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Selling, general and administrative

$

7,491

 

 

$

6,390

 

 

$

15,093

 

 

$

12,526

 

Research and development and engineering

 

1,152

 

 

 

649

 

 

 

2,542

 

 

 

1,264

 

Cost of revenue

 

612

 

 

 

459

 

 

 

1,416

 

 

 

808

 

Restructuring, acquisition, and related costs

 

581

 

 

 

—

 

 

 

581

 

 

 

—

 

Total share-based compensation expense

$

9,836

 

 

$

7,498

 

 

$

19,632

 

 

$

14,598

 
Schedule of Share Based Payment Award Performance Stock Awards Valuation Assumptions

The grant-date fair value per unit of the hybrid PSUs granted during the six months ended July 3, 2026 was estimated using the Monte Carlo valuation method with the following assumptions:

 

Six Months Ended July 3, 2026

 

Grant-date stock price

$

145.96

 

Expected volatility

 

40.80

%

Risk-free interest rate

 

3.44

%

Expected annual dividend yield

 

—

 

Fair value

$

173.88

 
Amended and Restated 2010 Incentive Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Restricted Stock Units Issued and Outstanding

The table below summarizes activities relating to RSUs issued and outstanding under the Company’s Amended and Restated 2010 Incentive Plan during the six months ended July 3, 2026:

 

Shares
(In thousands)

 

 

Weighted
Average Grant
Date Fair Value

 

Unvested at December 31, 2025

 

390

 

 

$

135.09

 

Granted

 

169

 

 

$

141.52

 

Vested

 

(182

)

 

$

133.66

 

Forfeited

 

(47

)

 

$

138.44

 

Unvested at July 3, 2026

 

330

 

 

$

139.24

 

Expected to vest as of July 3, 2026

 

300

 

 

 

 
Performance-Based Awards Issued and Outstanding

The table below summarizes the activities relating to the performance-based awards issued and outstanding under the Company’s Amended and Restated 2010 Incentive Plan during the six months ended July 3, 2026:

 

Shares
(In thousands)

 

 

Weighted
Average Grant-
Date Fair Value

 

Unvested at December 31, 2025

 

303

 

 

$

153.13

 

Granted

 

70

 

 

$

173.88

 

Performance adjustments(1)

 

(37

)

 

$

180.91

 

Vested

 

(54

)

 

$

164.96

 

Forfeited

 

(9

)

 

$

170.79

 

Unvested at July 3, 2026

 

273

 

 

$

151.72

 

Expected to vest as of July 3, 2026

 

230

 

 

 

 

(1) The amount shown represents performance adjustments related to the performance-based awards vested during the six months ended July 3, 2026.
Stock Options Issued and Outstanding

The table below summarizes the activities relating to stock options issued and outstanding under the Company’s Amended and Restated 2010 Incentive Plan during the six months ended July 3, 2026:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares
(In thousands)

 

 

Weighted
Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (years)

 

Aggregate Intrinsic Value(1) (In thousands)

 

Outstanding as of December 31, 2025

 

134

 

 

$

137.77

 

 

 

 

 

 

Granted

 

—

 

 

$

—

 

 

 

 

 

 

Exercised

 

(13

)

 

$

14.13

 

 

 

 

 

 

Forfeited or expired

 

—

 

 

$

—

 

 

 

 

 

 

Outstanding as of July 3, 2026

 

121

 

 

$

150.83

 

 

3.72 years

 

$

1,320

 

Exercisable as of July 3, 2026

 

106

 

 

$

149.88

 

 

3.59 years

 

$

1,256

 

Expected to vest as of July 3, 2026

 

15

 

 

$

157.48

 

 

4.64 years

 

$

64

 

(1)The aggregate intrinsic value is calculated as the difference between the closing market price of $161.72 per common share as of July 2, 2026 and the exercise price of the stock options.